Literature DB >> 19049433

Discovery of a "true" aspirin prodrug.

Louise M Moriarty1, Maeve N Lally, Ciaran G Carolan, Michael Jones, John M Clancy, John F Gilmer.   

Abstract

Aspirin prodrugs formed by derivatization at the benzoic acid group are very difficult to obtain because the promoiety accelerates the rate of hydrolysis by plasma esterases at the neighboring acetyl group, generating salicylic acid derivatives. By tracing the hydrolysis pattern of the aspirin prodrug isosorbide-2,5-diaspirinate (ISDA) in human plasma solution, we were able to identify a metabolite, isosorbide-2-aspirinate-5-salicylate, that undergoes almost complete conversion to aspirin by human plasma butyrylcholinesterase, making it the most successful aspirin prodrug discovered to date.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049433     DOI: 10.1021/jm801094c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.

Authors:  Carlos Medina; Shona Harmon; Iwona Inkielewicz; Maria Jose Santos-Martinez; Michael Jones; Paula Cantwell; Despina Bazou; Mark Ledwidge; Marek W Radomski; John F Gilmer
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.

Authors:  Patrick Masson; Daniel Rochu
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

3.  Stimuli-responsive nanomaterials for biomedical applications.

Authors:  Angela P Blum; Jacquelin K Kammeyer; Anthony M Rush; Cassandra E Callmann; Michael E Hahn; Nathan C Gianneschi
Journal:  J Am Chem Soc       Date:  2015-02-06       Impact factor: 15.419

4.  Identification of a potent Nrf2 displacement activator among aspirin-containing prodrugs.

Authors:  Irina N Gaisina; Dmitry M Hushpulian; Arsen M Gaisin; Eliot H Kazakov; Navneet Ammal Kaidery; Manuj Ahuja; Andrey A Poloznikov; Irina G Gazaryan; Gregory R J Thatcher; Bobby Thomas
Journal:  Neurochem Int       Date:  2021-07-27       Impact factor: 4.297

Review 5.  Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.

Authors:  Praveen P N Rao; Saad N Kabir; Tarek Mohamed
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.